Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

10.86
+0.47504.58%
Volume:119.46K
Turnover:1.25M
Market Cap:66.35M
PE:-0.21
High:10.86
Open:10.77
Low:9.96
Close:10.38
52wk High:309.60
52wk Low:9.10
Shares:6.11M
Float Shares:3.83M
Volume Ratio:0.94
T/O Rate:3.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-51.9692
EPS(LYR):-59.6431
ROE:-783.37%
ROA:-62.39%
PB:-0.71
PE(LYR):-0.18

Loading ...

Gossamer Bio Effects 1-for-80 Reverse Stock Split

Reuters
·
Sep 11

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 11

Gossamer Bio trading halted, news pending

TIPRANKS
·
Sep 11

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Sep 11

Gossamer Bio Announces 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 09

Gossamer Bio Highlights Seralutinib Phase 3 Prosera Data, Targets PAH NDA Filing

Reuters
·
Sep 08

Gossamer Bio to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 04

Gossamer Bio - Board Approves Amendment and Restatement of Bylaws Effective Sept 3, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 04

Gossamer Bio Cuts Shareholder Meeting Quorum Requirement to One-Third of Voting Power

Reuters
·
Sep 04

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 27

NASD Most Active Issues

Dow Jones
·
Aug 22

Gossamer Bio Agrees to Up to $250 Million Private Placement; Shares Rise Pre-Bell

MT Newswires Live
·
Aug 21

Gossamer Bio, - Proceeds Expected to Fund Operations into 2028

THOMSON REUTERS
·
Aug 21

Gossamer Bio, - $25 Mln Funded at Initial Closing, $125 Mln upon FDA Nda Acceptance

THOMSON REUTERS
·
Aug 21

Gossamer Bio Announces up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval

THOMSON REUTERS
·
Aug 21

Guggenheim Remains a Hold on Gossamer Bio (GOSS)

TIPRANKS
·
Aug 14

Gossamer Bio Q2 EPS $(0.08) Beats $(0.12) Estimate, Sales $9.238M Beat $5.193M Estimate

Benzinga Earnings
·
Aug 14

Gossamer Bio Q2 FY26 Returns to Profit at $16.9 Million; Revenue Falls 19.6% to $9.24 Million

Reuters
·
Aug 14

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

TIPRANKS
·
Aug 01

Gossamer Bio Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 01